The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 13, 2026

Filed:

Aug. 15, 2020
Applicant:

The Regents of the University of California, Oakland, CA (US);

Inventors:

Dennis A. Carson, La Jolla, CA (US);

Tomoko Hayashi, San Diego, CA (US);

Maripat Corr, San Diego, CA (US);

Howard B. Cottam, Escondido, CA (US);

Nikunj Shukla, San Diego, CA (US);

Michael Chan, San Diego, CA (US);

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 39/39 (2006.01); A61K 31/63 (2006.01); A61K 39/00 (2006.01); C12N 7/00 (2006.01); A61K 31/18 (2006.01); A61K 31/40 (2006.01); A61K 31/52 (2006.01); A61K 45/06 (2006.01); A61K 47/54 (2017.01); A61K 47/55 (2017.01);
U.S. Cl.
CPC ...
A61K 39/39 (2013.01); A61K 31/63 (2013.01); A61K 39/00 (2013.01); C12N 7/00 (2013.01); A61K 2039/55511 (2013.01);
Abstract

Bis-aryl sulfonamide compounds and methods of using those compounds, e.g., in a method of enhancing or prolonging an immune response, are provided. For example, the compounds may be employed with a vaccine and optionally at least one other adjuvant and/or one or more TLR ligands, at least one MAP kinase inhibitor, or any combination thereof.


Find Patent Forward Citations

Carson, Dennis. (2026). N-aryl sulfonamide derivatives as vaccine adjuvant (U.S. Patent No. 12758629). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12758629

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…